World's Best Scientists 2026 revealed!
VIEW LIST
George R. Blumenschein

D-Index & Metrics

Medicine

D-Index
91
Citations
52928
World Ranking
11509
National Ranking
5901

George R. Blumenschein publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where George R. Blumenschein sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 514 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

George R. Blumenschein D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where George R. Blumenschein sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

George R. Blumenschein is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily spans the field of Medicine with a strong focus on Oncology, specifically contributing to subfields such as Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, and Radiology, Nuclear Medicine and Imaging.

Blumenschein has published extensively on topics including Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, Lung Cancer Research Studies, CAR-T cell therapy research, and Lung Cancer Diagnosis and Treatment.

The scientist's recent papers cover various significant studies in oncology and lung cancer treatments:

  • Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153, 2020, Journal of Clinical Oncology
  • Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial, 2023, The Lancet
  • Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC, 2020, Journal of Thoracic Oncology
  • First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors, 2020, Journal of Clinical Oncology
  • Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial, 2023, Nature Medicine

Frequent collaborators of Blumenschein include John V. Heymach, Mehmet Altan, Anne S. Tsao, Yasir Y. Elamin, and Xiuning Le.

Their work is published predominantly in journals such as the Journal of Clinical Oncology, Journal of Thoracic Oncology, Regular and Young Investigator Award Abstracts, Cancer Research, and Annals of Oncology.

Best Publications

  • Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

    H. Borghaei;L. Paz-Ares;L. Horn;D. R. Spigel

  • Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

    Robert L. Ferris;George Blumenschein;Jerome Fayette;Joel Guigay

  • First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

    David P. Carbone;Martin Reck;Luis Paz-Ares;Benjamin Creelan

  • Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

    Jeffrey D. Bradley;Rebecca Paulus;Ritsuko Komaki;Gregory Masters

  • An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

    Lauren Averett Byers;Lixia Diao;Jing Wang;Pierre Saintigny

  • Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.

    Daniel R. Gomez;Chad Tang;Jianjun Zhang;George R. Blumenschein

  • Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

    Daniel R Gomez;George R Blumenschein;J Jack Lee;Mike Hernandez

  • Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion.

    Sewa S. Legha;Robert S. Benjamin;Bruce Mackay;Michael Ewer

  • The BATTLE Trial: Personalizing Therapy for Lung Cancer

    Edward S. Kim;Roy S. Herbst;Ignacio Ivan Wistuba;Jiun-Kae Jack Lee

  • Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.

    Robert L. Ferris;George Blumenschein;Jerome Fayette;Joel Guigay

  • Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer

    Roy S. Herbst;David H. Johnson;Eric Mininberg;David P. Carbone

  • Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

    Jordan U. Gutterman;George R. Blumenschein;Raymond Alexanian;Hwee-Yong Yap

  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.

    Tina Cascone;William N. William;Annikka Weissferdt;Cheuk H. Leung

  • Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

    Nathan T. Ihle;Lauren Averett Byers;Edward S. Kim;Pierre Saintigny

  • Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

    David R. Spigel;Thomas J. Ervin;Rodryg A. Ramlau;Davey B. Daniel

  • Pathological Assessment of Response to Induction Chemotherapy in Breast Cancer

    Lorne D. Feldman;Gabriel N. Hortobagyi;Aman U. Buzdar;Frederick C. Ames

  • Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

    Everett E. Vokes;N. Ready;E. Felip;L. Horn

  • Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

    Jeffrey D. Bradley;Chen Hu;Ritsuko R. Komaki;Gregory A. Masters

  • Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

    Kevin J Harrington;Robert L Ferris;George Blumenschein;A Dimitrios Colevas

  • Early and delayed clinical cardiotoxicity of doxorubicin.

    Aman U. Buzdar;Connie Marcus;George R. Blumenschein;Terry L. Smith

Frequent Co-Authors

Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center
Vassiliki A. Papadimitrakopoulou
Vassiliki A. Papadimitrakopoulou The University of Texas MD Anderson Cancer Center
Aman U. Buzdar
Aman U. Buzdar The University of Texas MD Anderson Cancer Center
J. Jack Lee
J. Jack Lee The University of Texas MD Anderson Cancer Center
Merrill S. Kies
Merrill S. Kies The University of Texas MD Anderson Cancer Center
Bonnie S. Glisson
Bonnie S. Glisson The University of Texas MD Anderson Cancer Center
Waun Ki Hong
Waun Ki Hong The University of Texas MD Anderson Cancer Center
Roy S. Herbst
Roy S. Herbst Yale University
Charles Lu
Charles Lu The University of Texas MD Anderson Cancer Center

External Links

Personal website of George R. Blumenschein

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the world of medicine in the USA opens doors to many specialized and flexible online programs. For students interested in mental health, there are psych np online programs which prepare graduates for high-demand roles as psychiatric nurse practitioners.

Leadership and management are also vital in healthcare. Pursuing an affordable healthcare administration degree online can lead to careers in hospital administration, clinical management, or healthcare consulting. For those looking to further specialize, consider the cheapest master's in healthcare administration options, which blend business skills with healthcare expertise.

If you are ready for an advanced clinical or leadership role, the most affordable online dnp programs can provide a cost-effective way to earn a Doctor of Nursing Practice degree. With many accredited and flexible pathways available, online health degrees make it easier to advance your medical career while balancing work and other commitments.

Best Scientists Citing George R. Blumenschein

Gabriel N. Hortobagyi

Gabriel N. Hortobagyi

The University of Texas MD Anderson Cancer Center

Publications: 169

John V. Heymach

John V. Heymach

The University of Texas MD Anderson Cancer Center

Publications: 94

Ignacio I. Wistuba

Ignacio I. Wistuba

The University of Texas MD Anderson Cancer Center

Publications: 74

Robert L. Ferris

Robert L. Ferris

University of Pittsburgh

Publications: 73

Zhongxing Liao

Zhongxing Liao

The University of Texas MD Anderson Cancer Center

Publications: 73

Roy S. Herbst

Roy S. Herbst

Yale University

Publications: 71

Aman U. Buzdar

Aman U. Buzdar

The University of Texas MD Anderson Cancer Center

Publications: 68

Suresh S. Ramalingam

Suresh S. Ramalingam

Emory University

Publications: 65

Jordan U. Gutterman

Jordan U. Gutterman

The University of Texas MD Anderson Cancer Center

Publications: 60

Benjamin Besse

Benjamin Besse

University of Paris-Saclay

Publications: 58

Dirk De Ruysscher

Dirk De Ruysscher

Maastricht University

Publications: 57

Martin Reck

Martin Reck

LungenClinic Grosshansdorf

Publications: 57

Razelle Kurzrock

Razelle Kurzrock

Medical College of Wisconsin

Publications: 56

J. Jack Lee

J. Jack Lee

The University of Texas MD Anderson Cancer Center

Publications: 55

Lisa Licitra

Lisa Licitra

University of Milan

Publications: 54

Ming-Sound Tsao

Ming-Sound Tsao

Princess Margaret Cancer Centre

Publications: 51

Trending Scientists

Pedro H. C. Camargo

Pedro H. C. Camargo

University of Helsinki

Joel C. Eissenberg

Joel C. Eissenberg

Saint Louis University

Karina W. Davidson

Karina W. Davidson

Feinstein Institute for Medical Research

Madan M. Aggarwal

Madan M. Aggarwal

Panjab University

Justin S. Mankin

Justin S. Mankin

Dartmouth College

Philip C. Bennett

Philip C. Bennett

The University of Texas at Austin

Michael C. Mahaney

Michael C. Mahaney

The University of Texas Rio Grande Valley

Johann Deisenhofer

Johann Deisenhofer

The University of Texas Southwestern Medical Center

Joel Z. Leibo

Joel Z. Leibo

DeepMind (United Kingdom)

Claus H. Christensen

Claus H. Christensen

Aarhus University

Jun Cheng

Jun Cheng

Xiamen University

Cheng-Gang Niu

Cheng-Gang Niu

Hunan University

Yong Liang

Yong Liang

Jianghan University

Graeme Auld

Graeme Auld

Carleton University

Bernard De Bruyne

Bernard De Bruyne

Cardiovascular Center Aalst

Jonathan Myers

Jonathan Myers

Washington University in St. Louis

Related Medicine Rankings & Guides

2026 Best Online Nursing Programs in Maine – Accredited RN to BSN Programs

2026 Best Online Nursing Programs in Maine – Accredited RN to BSN Programs
2026 Most Affordable Online AGNP Programs

2026 Most Affordable Online AGNP Programs
August 2026 Best Online Certificate Programs in Medical Billing & Coding Programs

August 2026 Best Online Certificate Programs in Medical Billing & Coding Programs
2026 Easiest LPN Programs to Get Into

2026 Easiest LPN Programs to Get Into
August 2026 Best Online Kinesiology Programs

August 2026 Best Online Kinesiology Programs
2026 Best Online Associate in Sonography Programs

2026 Best Online Associate in Sonography Programs
2026 Easiest Direct-Entry MSN Programs to Get Into

2026 Easiest Direct-Entry MSN Programs to Get Into
2026 Best Online Nursing Degree Programs

2026 Best Online Nursing Degree Programs
2026 Most Affordable Online FNP Programs

2026 Most Affordable Online FNP Programs
2026 Best Nurse Practitioner Programs in Arizona – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in Arizona – Accredited Schools Online & Campus
2026 Best Online Adult-Gerontology ACNP Graduate Certificate Programs

2026 Best Online Adult-Gerontology ACNP Graduate Certificate Programs
2026 Best Online Nursing Degree Programs for Non-Nurses

2026 Best Online Nursing Degree Programs for Non-Nurses
2026 Best Nurse Practitioner Programs in South Carolina – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in South Carolina – Accredited Schools Online & Campus
2026 Easiest Accelerated BSN Programs to Get Into

2026 Easiest Accelerated BSN Programs to Get Into
2026 Best Pathways to Pursue MSN without a BSN Degree

2026 Best Pathways to Pursue MSN without a BSN Degree
2026 Best Second-Degree BSN Programs

2026 Best Second-Degree BSN Programs
2026 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus
2026 Best Online BSN to FNP Programs

2026 Best Online BSN to FNP Programs
2026 Best Nurse Practitioner Programs in California – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in California – Accredited Schools Online & Campus
2026 Most Affordable Online Licensed Practical Nurse (LPN) Programs

2026 Most Affordable Online Licensed Practical Nurse (LPN) Programs
2026 Best Shortest Online PMHNP Certificate Programs

2026 Best Shortest Online PMHNP Certificate Programs

Recently Published Articles

2026 How To Become a Public Health Nurse: Salary & Career Paths

2026 How To Become a Public Health Nurse: Salary & Career Paths
2026 Most Affordable Online Medical Billing and Coding Courses

2026 Most Affordable Online Medical Billing and Coding Courses
2026 Best Online Bachelor’s Degree in Forensic Psychology Programs

2026 Best Online Bachelor’s Degree in Forensic Psychology Programs
2026 Best Accelerated Construction Management Degree Programs Online

2026 Best Accelerated Construction Management Degree Programs Online
2026 Online SLP Programs That Accept Low GPA Applicants

2026 Online SLP Programs That Accept Low GPA Applicants
2026 Best Accredited Online Graphic Design Bachelor's Degree Programs

2026 Best Accredited Online Graphic Design Bachelor's Degree Programs
2026 Online Mathematics Bachelor's Degree Programs for Adult Learners Returning to School

2026 Online Mathematics Bachelor's Degree Programs for Adult Learners Returning to School
2026 Online Special Education Master's Degree Program Costs: Tuition & Fees

2026 Online Special Education Master's Degree Program Costs: Tuition & Fees
2026 Is a Game Design Degree Worth It?

2026 Is a Game Design Degree Worth It?
2026 How to Become a Marriage and Family Therapist in North Carolina: Requirements & Certification

2026 How to Become a Marriage and Family Therapist in North Carolina: Requirements & Certification
2026 Can You Get Financial Aid for an Online Photography Bachelor's Degree?

2026 Can You Get Financial Aid for an Online Photography Bachelor's Degree?
2026 Most Affordable Online Information Technology Degrees

2026 Most Affordable Online Information Technology Degrees
2026 Taxation Degree Coursework Explained: What Classes Can You Expect to Take?

2026 Taxation Degree Coursework Explained: What Classes Can You Expect to Take?
2026 Best Accredited Online Geosciences Bachelor's Degree Programs

2026 Best Accredited Online Geosciences Bachelor's Degree Programs
2026 Cheapest and Shortest Online Real Estate Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2026 Cheapest and Shortest Online Real Estate Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2026 Can You Get a Forensic Science Degree Master's Without a Related Bachelor's Degree?

2026 Can You Get a Forensic Science Degree Master's Without a Related Bachelor's Degree?
2026 One-Year Online School Counseling Master's Degree Programs: Accelerated Options, Costs & Outcomes

2026 One-Year Online School Counseling Master's Degree Programs: Accelerated Options, Costs & Outcomes
2026 Which Native American Leadership Degree Careers Offer the Best Work-Life Balance?

2026 Which Native American Leadership Degree Careers Offer the Best Work-Life Balance?
2026 What Can You Do With a Health Information Management Degree

2026 What Can You Do With a Health Information Management Degree
2026 Most Affordable Online Christian Ministry Degree Programs

2026 Most Affordable Online Christian Ministry Degree Programs
2026 Is an Information Technology Master's Degree Worth It? ROI, Salary & Career Impact

2026 Is an Information Technology Master's Degree Worth It? ROI, Salary & Career Impact